Brady Corp: Form 10-Q for the period ended Apr 30, 2017
Filed with the SEC on May 25, 2017 and accepted by EDGAR at May 25, 2017, 07:13 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2017-04-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2017-02-01 to 2017-04-30 | $275.9m | us-gaap:SalesRevenueGoodsNet |
| Revenue | 9 months2016-08-01 to 2017-04-30 | $824.1m | us-gaap:SalesRevenueGoodsNet |
| Cost of revenue | 3 months2017-02-01 to 2017-04-30 | $136.0m | us-gaap:CostOfGoodsSold |
| Cost of revenue | 9 months2016-08-01 to 2017-04-30 | $409.7m | us-gaap:CostOfGoodsSold |
| Gross profit | 3 months2017-02-01 to 2017-04-30 | $139.9m | us-gaap:GrossProfit |
| Gross profit | 9 months2016-08-01 to 2017-04-30 | $414.4m | us-gaap:GrossProfit |
| Research and development | 3 months2017-02-01 to 2017-04-30 | $9.9m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2016-08-01 to 2017-04-30 | $28.6m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2017-02-01 to 2017-04-30 | $98.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2016-08-01 to 2017-04-30 | $291.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2017-02-01 to 2017-04-30 | $31.6m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2016-08-01 to 2017-04-30 | $94.7m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2017-02-01 to 2017-04-30 | $1.4m | us-gaap:InterestExpense |
| Interest expense | 9 months2016-08-01 to 2017-04-30 | $4.6m | us-gaap:InterestExpense |
| Income tax | 3 months2017-02-01 to 2017-04-30 | $8.1m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2016-08-01 to 2017-04-30 | $20.3m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2017-02-01 to 2017-04-30 | $22.6m | us-gaap:NetIncomeLoss |
| Net income | 9 months2016-08-01 to 2017-04-30 | $70.4m | us-gaap:NetIncomeLoss |
| Diluted shares (weighted) | 3 months2017-02-01 to 2017-04-30 | 52,201,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2016-08-01 to 2017-04-30 | 51,882,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2016-08-01 to 2017-04-30 | $91.2m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2016-08-01 to 2017-04-30 | $10.9m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months2016-08-01 to 2017-04-30 | $31.4m | us-gaap:PaymentsOfDividends |
| Share repurchases | 9 months2016-08-01 to 2017-04-30 | $0 | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2017-04-30 | $129.1m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2017-04-30 | $392.7m | us-gaap:AssetsCurrent |
| Total assets | At period end2017-04-30 | $1.01bn | us-gaap:Assets |
| Current liabilities | At period end2017-04-30 | $158.1m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2017-04-30 | $349.2m | us-gaap:Liabilities |
| Long-term debt | At period end2017-04-30 | $133.9m | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | At period end2017-04-30 | $664.1m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000746598-17-000042. Last ingested by Listed: Nov 9, 2026, 17:29 ET. Listed shows no prices and gives no investment advice.